[ad_1]
President Gitan Nauseda is also not abandoning the idea of vaccinating the vaccine, said his adviser.
“Of course, there could be doubts,” Asta Skaisgirytė told News Radio on Tuesday.
In early March, Nausėda said she was ready to get vaccinated with AstraZeneca when it was her turn.
“For AstraZeneca, the information is quite contradictory. The World Health Organization denies such cases, as do the manufacturers. No fatal complications have been reported in Lithuania either,” he said.
The Senior Advisor noted that around 17 million people had been vaccinated with AstraZeneca. people in the world, and “fatal returns when blood clots form” have been reported 37 times.
“If we take proportionally and compare, then those numbers are very small, considering the total number of people vaccinated,” said A. Skaisgirytė.
Prime Minister Ingrida Šimonytė also told Lithuanian radio on Tuesday that the AstraZeneca vaccine was registered in the European Union (EU), the European Medicines Agency has not yet confirmed the link between clot formation and vaccines.
According to the head of government, the decisions of other EU countries to temporarily suspend vaccination with this vaccine are preventive.
“I really regret what is likely to happen now, because all these decisions seem like preventive measures, but the vaccine itself is probably not a very good decision for its reputation because, say, our neighbors, there really is no basis for such a decision, talks about prevention “, – stated I. Šimonytė.
“There are no findings from the authorities that this vaccine is in any way inappropriate and would cause adverse effects directly related to vaccination. Every day we lose a few or a dozen people who die in a fight, so I would say discontinue the vaccination at this point would do more harm than good, ”he said.
The Prime Minister said that the use of the AstraZeneca vaccine is not hampered in many countries.
According to the Head of Government, in Lithuania a suspension decision could be made if there was a corresponding recommendation from the State Medicines Control Agency.
“But there is no such recommendation at this time,” he said.
Several EU countries, including Latvia, have reported stopping COVID-19 vaccination with AstraZeneca due to possible clot formation.
The European Medicines Agency will hold a special meeting on the vaccine on Thursday.
At that time, the World Health Organization asked countries to continue using this vaccine. It said its experts would assess the safety of the AstraZeneca product on Tuesday.
It is not allowed to publish, quote or reproduce the information of the BNS news agency in the media and on websites without the written consent of the UAB “BNS”.
[ad_2]
